<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55384121/cellares-increases-series-d-financing-to-327m-to-fund-commercial-scale-operations</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-15T14:31:08.000Z</news:publication_date><news:title>Cellares increases Series D financing to $327M to fund commercial-scale operations</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55384159/recipharm-makes-investment-in-us-operations-to-boost-fill-finish-capabilities</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-15T14:30:45.000Z</news:publication_date><news:title>Recipharm makes investment in US operations to boost fill-finish capabilities </news:title></news:news></url></urlset>